{
    "2019-08-26": [
        [
            {
                "time": "",
                "original_text": "贝达药业：上半年净利润同比增长30.99%",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "净利润",
                        "同比增长",
                        "30.99%"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“抗癌第一股”贝达药业上市3年10高管出走 超98%营收靠单一产品支撑新药研发暂停 董监高成员变化",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "抗癌第一股",
                        "高管出走",
                        "98%营收",
                        "单一产品",
                        "新药研发暂停",
                        "董监高成员变化"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}